Complement deficiency and systemic lupus erythematosus: Consensus and dilemma

Expert Review of Clinical Immunology

Volumn 4, Issue 5, 2008, Pages 629-637

  Kallel Sellami, Maryam ^a   Laadhar, Lilia ^a   Zerzeri, Yousr ^a   Makni, Sondes ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Antinuclear antibody; C1q; C2; C4; Complement; Hereditary deficiency; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4;

ANTIGEN ANTIBODY COMPLEX; BRAIN VASCULITIS; CAUCASIAN; CLINICAL FEATURE; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEFICIENCY; GENE TARGETING; GLOMERULONEPHRITIS; HAPLOTYPE; HETEROZYGOSITY; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION; LUPUS VULGARIS; ONSET AGE; PATHOPHYSIOLOGY; RAYNAUD PHENOMENON; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 77649112291     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.4.5.629     Document Type: Review

References (63)

1. Cooper NR. Complement: a nostalgic journey. Mol. Immunol. 43, 487-495 (2006).
2. Pillemer L, Blum L, Lepow IH. The properdin system and immunity. Demonstration and isolation of a new serum, properdin. Its role in human phenomena. Science 120, 279-285 (1954).
3. Wolfgang MP, Reinhard W, Heribert S, Manfred PD. Complement. In: Fundamental Immunology (5th Edition). Paul WE (Ed.). Lippincott, Williams and Wilkins, PA, USA 1077-1103 (2003).
4. Waloport MJ. Complement first of two parts. N. Engl. J. Med. 344, 1058-1066 (2001).
5. Esser AF. Big MAC attack: complement proteins cause leaky patches. Immunol. Today 12, 316-318 (1991).
6. Elliott JA, Mathieson DR. Complement in disseminated (systemic) lupus eythematosus. AMA. Arch. Dermat. Syphilol. 68, 119-128 (1953).
7. Walport MJ. Complement second of two parts. N. Engl. J. Med. 344(15), 1140-1144 (2001).
8. Pickering MC, Walport MJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology 39, 133-141 (2000).
9. Kallel Sellami M, Baili Klila L, Zerzeri Y et al. Pediatric systemic lupus erythematosus with C1q deficiency. Ann. NY Acad. Sci. 1108, 193-196 (2007).
10. Marquart HV, Schejbel L, Sjoholm A et al. C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations. Clin. Immunol. 124, 33-40 (2007).
11. Bowness P, Davies KA, Norsworthy PJ et al. Hereditary C1q deficiency and systemic lupus erythematosus. QJM 87(8), 455-464 (1994).
12. Sontheimer RD, Racila E, Racila DM. C1q: its function within the innate and adaptative immune responses and its role in lupus autoimmunity. J. Invest. Dermatol. 125, 14-23 (2005).
13. Kusumoto H, Hirosawa S, Salier JP, Hagen FS, Kurachi K. Human genes for complement components C1r and C1s in a close tail-to-tail arrangement. Proc. Natl Acad. Sci. USA 85, 7307-7311 (1988).
14. Amanoa MT, Ferriani V P, Florido MP et al. Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s gene. Mol. Immunol. 45, 1693-1702 (2008).
15. Endo Y, Kanno K, Takahashi M et al. Molecular basis of human complement C1s deficiency. J. Immunol. 162, 2180-2183 (1999).
16. Inoue N, Saito T, Masuda R et al. Selective complement C1s deficiency caused by homozygous four-base deletion in the C1s gene. Hum. Genet. 103, 415-418 (1998).
17. Dragon-Durey MA, Quartier P, Fremeaux-Bacchi V et al. Molecular basis of a selective C1s deficiency associated with early onset multiple autoimmune diseases. J. Immunol. 166, 7612-7616 (2001).
18. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res. 4(Suppl. 3), S279-S293 (2002).
19. Sullivan KE, Petri MA, Schmeckpeper BJ, McLean RH, Winkelstein JA. Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus. J. Rheumatol. 21(6), 1128-1133 (1994).
20. Truedsson L, Sturfelt G, Nived O. Prevalence of type I complement C2 deficiency gene on Swedish systemic lupus erythematosus patients. Lupus 2(5), 325-327 (1993).
21. Ratnoff WD. Inherited deficiencies of complement in rheumatic diseases. Rheum. Dis. Clin. North Am. 22, 75-94 (1996).
22. Jönsson G, Sjöholm AG, Truedsson L, Bengtsson AA, Braconier JH, Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. Rheumatology (Oxford) 46(7), 1133-1139 (2007).
23. Lipsker DM, Schreckenberg-Gilliot C, Uring-Lambert B et al. Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch. Dermatol. 136(12), 1508-1514 (2000).
24. Jönsson G, Truedsson L, Sturfelt G, Oxelius VA, Braconier JH, Sjöholm AG. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore) 84(1), 23-34 (2005).
25. Kallel Sellami M, Baili Klila L, Zerzeri Y et al. Hereditary complement deficiency and lupus: report of 4 Tunisian cases. Ann. NY Acad. Sci. 1108, 197-202 (2007).
26. Ratnoff WD. Inherited C2 deficiency of complement in rheumatic diseases. Rheum. Dis. Clin. North Am. 22, 75-94 (1996).
27. Johnson CA, Densen P, Hurford RK, Colten HR, Wetsel RA. Type I human complement C2 deficiency: a 28-base-pair gene deletion causes skipping of exon 6 during RNA splicing. J. Biol. Chem. 267, 9347-9353 (1992).
28. Mauff G, Luther B, Schneider PM et al. Reference typing report for complement component C4. Exp. Clin. Immunogenet. 15, 249-260 (1998).
29. Dangel AW, Mendoza AR, Baker BJ et al. The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 40, 425-436 (1994).
30. Yang Z, Mendoza AR, Welch TR, Zipf WB, Yu CY. Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21 and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations. J. Biol. Chem. 274(17), 12147-12156 (1999).
31. Yang Y, Chung EK, Zhou B et al. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J. Immunol. 171(5), 2734-2745 (2003).
32. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76, 227-324 (2000).
33. Yu CY, Whitacre CC. Sex, MHC and complement C4 in autoimmune diseases. Trends Immunol. 25(12), 694-699 (2004).
34. Atkinson JP, Scheinder PM. Genetic susceptibility and class III complement genes. In: Systemic Lupus Erythematosus (4th Edition). Lahita RG (Ed.). Elsevier-Academic Press, CA, USA 153-201 (2004).
35. Yang Y, Chung EK, Zhou B et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr. Dir. Autoimmun. 7, 98-132 (2004).
36. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22, 431-456 (2004).
37. Lokki ML, Circolo A, Ahokas P, Rupert KL, Yu CY, Colten HR. Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes. J. Immunol. 162(6), 3687-3693 (1999).
38. Fredrikson GN, Gullstrand B, Schneider PM et al. Characterization of nonexpressed C4 genes in a case of complete C4 deficiency: identification of a novel point mutation leading to premature stop codon. Hum. Immunol. 59(11), 713-719 (1998).
39. Naves M, Hajeer AH, Teh LS et al. Complement C4B null alleles confers risk for systemic lupus erythematosus in a Spanish population. Eur. J. Immunogenet. 25, 317-320 (1998).
40. Ranford P, Hay J, Serjeantson SW, Dunckley H. A high frequency of inherited deficiency of complement component C4 in Darwin Aborigines. Aust. NZ Med. 17, 420-423 (1987).
41. Reveille JD, Moulds JM, Ahn C et al. Systemic lupus erythematosus in three ethnic groups. I. The effects of HLA class II, C4 and CRI alleles, socioeconomic factors and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 41, 1161-1172 (1998).
42. Man XY, Luo HR, Li XP, Yao YG, Mao CZ, Zhang YP. Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: Association with systemic lupus erythematosus in Southwest Han Chinese. Ann. Rheum. Dis. 62, 71-73 (2003).
43. Yang Y, Chung EK, Wu YL et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am. J. Hum. Genet. 80(6), 1037-1054 (2007).
44. Koide M, Shirahama S, Tokura Y, Takigawa M, Hayakawa M, Furukawa F. Lupus erythematosus associated with C1 inhibitor deficiency. J. Dermatol. 29(8), 503-507 (2002).
45. Khan S, Tarzi MD, Doré PC, Sewell WA, Longhurst HJ. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clin. Immunol. 123(1), 14-17 (2007).
46. Cornacoff JB, Hebert LA, Smead WL, VanAman ME, Birmingham DJ, Waxman FJ. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71(2), 236-247 (1983).
47. Walport M, Ng YC, Lachmann PJ. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface. Clin. Exp. Immunol. 69(3), 501-507 (1987).
48. Walport MJ, Davies KA. Complement and immune complexes. Res. Immunol. 147, 103-109 (1996).
49. Traustadottir KH, Sigfusson A, Steinsson K, Erlendsson K. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus. J. Rheumatol. 29(11), 2359-2366 (2002).
50. Rupert KL, Moulds JM, Yang Y et al. The molecular basis of complete complement C4A and C4B deficiencies in a systemic lupus erythematosus patient with homozygous C4A and C4B mutant genes. J. Immunol. 169(3), 1570-1578 (2002).
51. Ravetch JV, Clynes RA. Divergent roles for Fc receptor and complement in vivo. Annu. Rev. Immunol. 16, 421-432 (1998).
52. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 205(4-5), 395-406 (2002).
53. Mitchell DA, Pickering MC, Warren J et al. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168(5), 2538-2543 (2002).
54. Ferry H, Potter PK, Crockford TL et al. Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in C1q-deficient mice. J. Immunol. 178(5), 2916-2922 (2007).
55. Prodeus AP, Goerg, LM, Shen O et al. A critical role for complement in maintenance of self-tolerance. Immunity 9, 721-731 (1998).
56. Finke D, Randers K, Hoerster R et al. Elevated levels of endogenous apoptotic DNA and IFN-α in complement C4-deficient mice: implications for induction of systemic lupus erythematosus. Eur. J. Immunol. 37(6), 1702-1709 (2007).
57. Boeckler P, Milea M, Meyer A et al. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; focus on C2/C4 deficiency. Br. J. Dermatol. 152(2), 265-270 (2005).
58. Erlendsson K, Traustadóttir K, Freysdóttir J, Steinsson K, Jónsdóttir I, Valdimarsson H. Reciprocal changes in complement activity and immune-complex levels during plasma infusion in a C2-deficient SLE patient. Lupus 2(3), 161-165 (1993).
59. Steinsson K, Erlendsson K, Valdimarsson H. Successful plasma infusion treatment of a patient with C2 deficiency and systemic lupus erythematosus: clinical experience over forty-five months. Arthritis Rheum. 32(7), 906-913 (1989).
60. Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin. Exp. Immunol. 139, 379-394 (2005).
61. Petry F, Botto M, Holtappels R, Walport MJ, Loos M. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. J. Immunol. 167(7), 4033-4037 (2001).
62. Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 35(8), 2496-2506 (2005).
63. Bao L, Osawe I, Haas M, Quigg RJ. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J. Immunol. 175(3), 1947-1955(2005).